Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Valuation of the anti-virus platform

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Mar 30, 2022 8:59pm

156 Views

Post# 34561222

RE:RE:Valuation of the anti-virus platform

1 day ago -

Ontario has entered the sixth COVID-19 wave, doctors say

Ontario reported a more than +23% week-over-week increase in COVID-19 hospitalizations on Tuesday as one epidemiologist says the province is now in a sixth wave of the pandemic. The Ministry of Health says there are currently 790 patients with the virus in Ontario hospitals, compared to 639 a week ago.

1 day ago -